Mattila, K.E. et al. 2022. Circulating tumor DNA is a prognostic biomarker in metastatic melanoma patients treated with chemoimmunotherapy and BRAF inhibitor. Acta Oncologica. 61, 10 (Oct. 2022), 1263–1267. DOI:https://doi.org/10.1080/0284186X.2022.2137693.